Amol Akhade/X
Oct 29, 2025, 07:13
Amol Akhade: Happy To Share Our Paper Published In Lancet Oncology
Amol Akhade, Senior Medical and Hemato-Oncologist at Fortis Hospital Mumbai and Founder of Suyog Cancer Clinics, shared a post on X:
“Happy To Share Our Paper published In Lancet Oncology. It is joint venture between myself and Manju Sengar and Dr Roni Levin and Daniel Goldstein from Israel .
We closely looked at Subcut IO drugs approvals and discuss that even though sub cut formulations are more convenient they may actually prolong patents and may delay entry of Biosimilar IO drugs.
Wolf in Sheep clothing. Classic essay in Pharmaco Economics”
Title: Subcutaneous immunotherapy—a wolf in sheep’s clothing?
Authors: Roni Levin, Amol Akhade, Manju Sengar, Daniel A Goldstein
Read full paper here
Stay updated with Hemostasis Today.
-
Aug 14, 2026, 23:18Claire Hills: New Paper on Immune Surveillance and Immune Evasion of Senescent Cells
-
Aug 14, 2026, 23:16Are We Overlooking What Matters Most to Women with Von Willebrand Disease? – RPTH Journal
-
Aug 14, 2026, 23:15Markus Müller: A New Base Editing Approach Targeting PCSK9 to Lower Cholesterol Levels
-
Aug 14, 2026, 23:14Chokri Ben Lamine: Avatrombopag in Hematology – Dosing and Monitoring
-
Aug 14, 2026, 23:13Bianca Rocca: PRECISE-DAPT Score Identifies Bleeding Risk After CABG in Patients With POAF
-
Aug 14, 2026, 19:04Ravi Kumar: Why Lupus Anticoagulant Predicts Clots, Not Bleeding
-
Aug 14, 2026, 18:53Veli Bakalov: The Number Every Hematologist Should Know in Polycythemia Vera
-
Aug 14, 2026, 18:41Marta Velia Antonini: Can Nitric Oxide Protect the ECMO Circuit Without Systemic Anticoagulation?
-
Aug 14, 2026, 18:30Irina Gontschar: What the Epkinly FDA Review Teaches Us About Sponsor Oversight